Background Ovarian cancer is the seventh most common cancer among women and a
leading cause of death from gynaecological malignancies. Epithelial ovarian cancer is the …

The development of guidelines recommendations is one of the core activities of the
European Society for Medical Oncology (ESMO) and European Society of Gynaecologial …

Background Ovarian cancer survival rates have not changed in the last 20 years. The
majority of cases are High-grade serous ovarian carcinomas (HGSOCs), which are typically …

Highlights•46 participants from 15 countries across Europe, Asia and the USA contributed to
the ESGO–ESMO–ESP consensus conference.•Recommendations cover diagnosis and …

Background This study aimed to compare the outcomes of two distinct patient populations
treated within two neighboring UK cancer centers (A and B) for advanced epithelial ovarian …

Simple Summary In the era of personalized medicine, Artificial Intelligence (AI) has emerged
as a powerful tool with growing applications in the field of gynaecologic oncology. However …

PURPOSE To provide expert guidance to clinicians and policymakers in three resource-
constrained settings on diagnosis and staging of adult women with ovarian masses and …

Complete surgical cytoreduction (R0 resection) is the single most important prognosticator in
epithelial ovarian cancer (EOC). Explainable Artificial Intelligence (XAI) could clarify the …

Limited evidence exists on the impact of spatial and temporal heterogeneity of high-grade
serous ovarian cancer (HGSOC) on tumor evolution, clinical outcomes, and surgical …

Simple Summary Ovarian cancer is treated by surgery to remove all visible cancer and
chemotherapy. Cancer survival is highest when no cancer is left behind after surgery. Ultra …